

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucos⦠read more
Healthcare
Medical Devices
39 years
USD
Exclusive to Premium users
$40.93
Price+0.34%
$0.14
$2.177b
Mid
-
Premium
Premium
-4.6%
EBITDA Margin-31.9%
Net Profit Margin-2.0%
Free Cash Flow Margin-4.6%
EBITDA Margin-31.9%
Net Profit Margin-2.0%
Free Cash Flow Margin$238.105m
+5.7%
1y CAGR+14.6%
3y CAGR+14.6%
5y CAGR-$31.453m
-100.3%
1y CAGR-34.6%
3y CAGR-19.7%
5y CAGR-$0.63
-85.3%
1y CAGR-26.1%
3y CAGR-13.0%
5y CAGR$244.808m
$289.488m
Assets$44.680m
Liabilities$20.642m
Debt7.1%
3.6x
Debt to EBITDA$8.933m
+404.6%
1y CAGR-8753.0%
3y CAGR-6553.6%
5y CAGR